BH3 domains as BCL-2 inhibitors: prototype cancer therapeutics

Author: Letai Anthony  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.3, Iss.2, 2003-04, pp. : 293-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract